RAPT: RAPT Therapeutics Sotuvga nisbatan narx
RAPT Therapeutics, Inc. (RAPT) kompaniyasining baholanishi immun terapiyasi uchun kelgusidagi patent himoyasiga asoslangan bo'lib, bu kompaniyaga narxlarni belgilash imkoniyatini beradi. Sotuvlarga nisbatan narx koeffitsiyenti baholashning me'yordan og'ishlarini ko'rsatadi, bunda 810.70 qiymati metrika darajasini ifodalaydi. Joriy balans hisoboti klinik sinovlarning ehtiyotkorona moliyalashtirishi bilan ta'minlangan, onkologiya va yallig'lanish sohalaridagi R&D ishlanmalari esa o'sish potentsialini taqdim etadi.
RAPT Therapeutics, Inc. (RAPT) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning xususiy kapitalga nisbati RAPT Therapeutics, Inc.|RAPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati rapt.com|RAPT - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati RAPT|RAPT - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori RAPT Therapeutics|Oraliq qoplash koeffitsiyenti rapt.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
RAPT - Sof foyda|Kutilayotgan sof foyda RAPT Therapeutics, Inc.|RAPT - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori RAPT Therapeutics Inc.|RAPT - PEG multiplikatori|EV/EBITDA multiplikatori RAPT|RAPT - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda RAPT Therapeutics|RAPT - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi rapt.com|RAPT - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi RAPT Therapeutics, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:RAPT Therapeutics Inc., RAPT
Yuqori xavfli immunologik ishlanmalar segmentida faoliyat yurituvchi RAPT Therapeutics, Inc. (RAPT) uchun kompaniyaning P/S koeffitsiyenti uning patentlangan molekulalarini tijorchashtirishga oid bozor kutuvlarining ko'rsatkichi bo'lib xizmat qiladi. Ushbu koeffitsiyent bozor kapitalizatsiyasi va yillik daromadlar o'rtasidagi nisbat sifatida hisoblanadi, bu esa investorlarga joriy savdolar uchun to'langan premium miqdorini aniqlash va aktivning barqarorligini uning tarixiy qiymatlari bilan solishtirib baholash imkonini beradi.
RAPT Therapeutics, Inc. kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PTGX (Protagonist Corp)|IMVT: P/S multiplikatori|kiniksa.com (KNSA) - P/S multiplikatori|Narxning daromadga nisbati Grifols|Adaptive Biotech - Narxning sotuvga nisbati|Kapitalizatsiyaning daromadga nisbati CLDX (Celldex)|Kapitalizatsiyaning sotish hajmiga nisbati AUPH|BioCryst - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati VERA|DNTH: Kapitalizatsiyaning daromadga nisbati|Pharvaris NV - Kapitalizatsiyaning sotish hajmiga nisbati|ABCL: P/S multiplikatori|Tourmaline - Bozor kapitallashuvining daromadga nisbati|PGEN (Precigen, Inc.) - P/S multiplikatori|Sotuvga nisbatan narx pharming.com PHAR|Narxning daromadga nisbati Nektar Therapeutics Inc. (NKTR)|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|P/S multiplikatori Immunome Bio IMNM|GOSS - Narxning daromadga nisbati|Narxning sotuvga nisbati KALV|SEPN: P/S multiplikatori|Sotuvga nisbatan narx Pieris Pharma (PVLA)|Kapitalizatsiyaning daromadga nisbati SVRA|P/S multiplikatori Rigel Corp|Kapitalizatsiyaning daromadga nisbati ANAB (AnaptysBio, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati ATXS|P/S multiplikatori ENGN (enGene)|Narx/daromad koeffitsiyenti Aerovate Therapeutics, Inc. (JBIO)|Aclaris - P/S multiplikatori|Kyverna Therapeutics, Inc (KYTX) - Kapitalizatsiyaning daromadga nisbati|Tiziana Life Sciences (TLSA) - Narxning daromadga nisbati|CABA - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati VTYX|THTX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori AVTX|Narx/daromad koeffitsiyenti Eledon Pharmaceuticals, Inc|Narxning daromadga nisbati Agenus AGEN|CLYM: Kapitalizatsiya va daromad nisbati|Zura Bio - P/S multiplikatori|aTyr Pharma Inc (ATYR) - Kapitalizatsiyaning daromadga nisbati|ADAG (adagene.com) - Kapitalizatsiyaning daromadga nisbati|IMA - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Shattuck Labs Inc|EQ: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CNTB|P/S multiplikatori immunic-therapeutics.com (IMUX)|Narxning daromadga nisbati Atara Bio ATRA|IFRX (InflaRx NV) - Narxning sotuvga nisbati|XFOR: Kapitalizatsiyaning daromadga nisbati|Adicet Bio - Kapitalizatsiyaning sotish hajmiga nisbati|celularity.com (CELU) - Narxning daromadga nisbati|Narxning sotuvga nisbati INMB (INmune Bio Inc)|BRNS (Barinthus Bio) - P/S multiplikatori|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|P/S multiplikatori akaritx.com (AKTX)|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|Bozor kapitallashuvining daromadga nisbati QTTB|GOVX - Narxning daromadga nisbati|Edesa Biotech Corp (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|Carisma Therapeutics Inc. (CARM) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati XTLB|BOLT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HCWB|Narx/daromad koeffitsiyenti aptevotherapeutics.com|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI - Narxning daromadga nisbati|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (ReShape Lifesciences) - Kapitalizatsiyaning daromadga nisbati|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiya va daromad nisbati SCNI (scinai.com)|P/S multiplikatori CALI|AFMD - Sotuvga nisbatan narx|Narxning daromadga nisbati Allakos ALLK|Bozor kapitallashuvining daromadga nisbati HOOK|IGM Bio - P/S multiplikatori|ITOS - P/S multiplikatori|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|Narxning sotuvga nisbati TCBP (TC BioPharm (Holdings) Plc)|Kapitalizatsiyaning daromadga nisbati THRD
